Abiopharma

🔍 Philips Jeremy (Director)

Company: Angi Inc. (ANGI)

Report Date: 2026-06-10

Detailed Transactions and Holdings:

• Acquired 43,936 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 43,936.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock.
• F2: The restricted stock units vest in three equal annual installments beginning on the first anniversary of the grant date, subject to continued service through each vesting date. Pursuant to the reporting person's deferral election, any vested RSUs will be settled in a lump sum following termination of service.